For whom the bell tolls: isoniazid preventive therapy and tuberculosis drug resistance

Frank G. J. Cobelens

doi:https://doi.org/10.1126/scitranslmed.3006094

For whom the bell tolls: isoniazid preventive therapy and tuberculosis drug resistance

Frank G. J. Cobelens

Research output: Contribution to journal › Editorial › Academic › peer-review

2 Citations (Scopus)

Abstract

The expected increase in drug-resistant tuberculosis due to large-scale preventive treatment in people living with HIV calls for reconsidering the "double use" of isoniazid for prophylaxis and curative treatment (Mills et al., this issue)

Original language	English
Pages (from-to)	180fs12
Journal	Science Translational Medicine
Volume	5
Issue number	180
DOIs	https://doi.org/10.1126/scitranslmed.3006094
Publication status	Published - 2013

Access to Document

https://doi.org/10.1126/scitranslmed.3006094

Cite this

@article{8006a7eb1ba949d2b68f5dbcd3e985b3,

title = "For whom the bell tolls: isoniazid preventive therapy and tuberculosis drug resistance",

abstract = "The expected increase in drug-resistant tuberculosis due to large-scale preventive treatment in people living with HIV calls for reconsidering the {"}double use{"} of isoniazid for prophylaxis and curative treatment (Mills et al., this issue)",

author = "Cobelens, {Frank G. J.}",

year = "2013",

doi = "https://doi.org/10.1126/scitranslmed.3006094",

language = "English",

volume = "5",

pages = "180fs12",

journal = "Science Translational Medicine",

issn = "1946-6242",

publisher = "American Association for the Advancement of Science",

number = "180",

}

TY - JOUR

T1 - For whom the bell tolls: isoniazid preventive therapy and tuberculosis drug resistance

AU - Cobelens, Frank G. J.

PY - 2013

Y1 - 2013

N2 - The expected increase in drug-resistant tuberculosis due to large-scale preventive treatment in people living with HIV calls for reconsidering the "double use" of isoniazid for prophylaxis and curative treatment (Mills et al., this issue)

AB - The expected increase in drug-resistant tuberculosis due to large-scale preventive treatment in people living with HIV calls for reconsidering the "double use" of isoniazid for prophylaxis and curative treatment (Mills et al., this issue)

U2 - https://doi.org/10.1126/scitranslmed.3006094

DO - https://doi.org/10.1126/scitranslmed.3006094

M3 - Editorial

C2 - 23576813

SN - 1946-6242

VL - 5

SP - 180fs12

JO - Science Translational Medicine

JF - Science Translational Medicine

IS - 180

ER -